UCSF

Tagged: National Cancer Institute (NCI)

Study identifies lack of information about HER2 testing practices

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of HER2, trastuzumab can be highly effective.

UCSF researchers join consortium to target cancer in new ways

Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.

Phillips awarded $5 Million NCI grant to study personalized medicine

The wider world use of medical tests and treatments based on individual genetic differences is the focus of a new, US$5 million research program funded by the National Cancer Institute (NCI) and led by UCSF School of Pharmacy health economist Kathryn Phillips, PhD.

Health care providers to receive smoking cessation training

Pharmacy school faculties across the United States will be trained to teach a tobacco cessation curriculum to Doctor of Pharmacy students, and community pharmacists and physicians will be trained to work as a close-knit team when it comes to helping their patients quit smoking because of two recently funded grants from the National Cancer Institute and the leadership of UCSF School of Pharmacy investigators Karen Hud